Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Sep;26(9):1818–1823. doi: 10.1128/jcm.26.9.1818-1823.1988

Evaluation of serologic assays for diagnosis of whooping cough.

G Granström 1, B Wretlind 1, C R Salenstedt 1, M Granström 1
PMCID: PMC266723  PMID: 2903178

Abstract

An enzyme-linked immunosorbent assay (ELISA) for the immunoglobulin G (IgG), IgM, and IgA response to Bordetella pertussis filamentous hemagglutinin (FHA) and pertussis toxin (PT) and a neutralization test (NT) in a microplate tissue culture assay for neutralizing antibodies to PT were evaluated in paired sera from 90 patients with culture-confirmed pertussis. Eighty patients were children (age, less than 15 years), and 6 of 80 children had been immunized with three doses of diphtheria-tetanus-pertussis vaccine as infants. A significant titer rise (greater than or equal to twofold), determined by ELISA, of IgG, IgM, and IgA to FHA was recorded in 75 (83%), 28 (31%), and 47 (52%) of the patients, respectively. A significant titer rise to PT in IgG was found in 83 (92%), IgM in 29 (32%), and IgA in 44 (49%) of the patients. A significant titer rise to FHA or PT in IgG was found in 88 (98%) of the patients, in combination with a significant rise in the titer of IgA to FHA. These data were obtained in a single serum dilution of 1:500. Titrations performed later showed that the titer rise to FHA in IgG was a mean of 6.5-fold, which was significantly lower than the mean 67.0-fold rise in IgG to PT (P less than 0.001). The mean titer of IgG to FHA in convalescent-phase serum was 270, which was also significantly lower than the mean PT titer of 2,943 (P less than 0.001). A significant rise (greater than or equal to fourfold) in PT titer by NT was found in 58 of 83 (70%) of the patients. The NT was significantly less sensitive than the ELISA for the determination of the IgG titer to PT ( P< 0.001). Results showed that a 100% (90 of 90) sensitivity in terms of titer rises was achieved in the serologic diagnosis of pertussis by ELISA in a single-point determination of the IgG and IgA responses to FHA and of the IgG response to PT.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askelöf P., Granström M., Gillenius P., Lindberg A. A. Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay. J Med Microbiol. 1982 Feb;15(1):73–83. doi: 10.1099/00222615-15-1-73. [DOI] [PubMed] [Google Scholar]
  2. Blennow M., Granström M., Olin P., Tiru M., Jätmaa E., Askelöf P., Sato Y. Preliminary data from a clinical trial (phase 2) of an acellular pertussis vaccine, J-NIH-6. Dev Biol Stand. 1986;65:185–190. [PubMed] [Google Scholar]
  3. Burstyn D. G., Baraff L. J., Peppler M. S., Leake R. D., St Geme J., Jr, Manclark C. R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun. 1983 Sep;41(3):1150–1156. doi: 10.1128/iai.41.3.1150-1156.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler J. E., Feldbush T. L., McGivern P. L., Stewart N. The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity. Immunochemistry. 1978 Feb;15(2):131–136. doi: 10.1016/0161-5890(78)90053-6. [DOI] [PubMed] [Google Scholar]
  5. Finger H., Wirsing von Koenig C. H. Serological diagnosis of whooping cough. Dev Biol Stand. 1985;61:331–335. [PubMed] [Google Scholar]
  6. Gillenius P., Jätmaa E., Askelöf P., Granström M., Tiru M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand. 1985 Jan;13(1):61–66. doi: 10.1016/s0092-1157(85)80034-2. [DOI] [PubMed] [Google Scholar]
  7. Granström G., Sterner G., Nord C. E., Granström M. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J Infect Dis. 1987 Jun;155(6):1210–1214. doi: 10.1093/infdis/155.6.1210. [DOI] [PubMed] [Google Scholar]
  8. Granström M., Granström G., Gillenius P., Askelöf P. Neutralizing antibodies to pertussis toxin in whooping cough. J Infect Dis. 1985 Apr;151(4):646–649. doi: 10.1093/infdis/151.4.646. [DOI] [PubMed] [Google Scholar]
  9. Granström M., Granström G., Lindfors A., Askelöf P. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. J Infect Dis. 1982 Dec;146(6):741–745. doi: 10.1093/infdis/146.6.741. [DOI] [PubMed] [Google Scholar]
  10. Granström M., Lindberg A. A., Askelöf P., Hederstedt B. Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay. J Med Microbiol. 1982 Feb;15(1):85–96. doi: 10.1099/00222615-15-1-85. [DOI] [PubMed] [Google Scholar]
  11. Hedenskog S., Granström M., Olin P., Tiru M., Sato Y. A clinical trial of a monocomponent pertussis toxoid vaccine. Am J Dis Child. 1987 Aug;141(8):844–847. doi: 10.1001/archpedi.1987.04460080030021. [DOI] [PubMed] [Google Scholar]
  12. Kwantes W., Joynson D. H., Williams W. O. Bordetella pertussis isolation in general practice: 1977-79 whooping cough epidemic in West Glamorgan. J Hyg (Lond) 1983 Apr;90(2):149–158. doi: 10.1017/s0022172400028825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lawrence A. J., Paton J. C. Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. J Clin Microbiol. 1987 Nov;25(11):2102–2104. doi: 10.1128/jcm.25.11.2102-2104.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lehtonen O. P., Eerola E. The effect of different antibody affinities on ELISA absorbance and titer. J Immunol Methods. 1982 Oct 29;54(2):233–240. doi: 10.1016/0022-1759(82)90064-3. [DOI] [PubMed] [Google Scholar]
  15. Nagel J., Poot-Scholtens E. J. Serum IgA antibody to Bordetella pertussis as an indicator of infection. J Med Microbiol. 1983 Nov;16(4):417–426. doi: 10.1099/00222615-16-4-417. [DOI] [PubMed] [Google Scholar]
  16. Sato Y., Sato H. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children. Dev Biol Stand. 1985;61:367–372. [PubMed] [Google Scholar]
  17. Viljanen M. K., Ruuskanen O., Granberg C., Salmi T. T. Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis. 1982;14(2):117–122. doi: 10.3109/inf.1982.14.issue-2.08. [DOI] [PubMed] [Google Scholar]
  18. Winsnes R., Lønnes T., Møgster B., Berdal B. P. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Dev Biol Stand. 1985;61:353–365. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES